| Joy J Kain, MD | |
|
865 Westfield Rd Ste B, Noblesville, IN 46062-8901 | |
| (317) 776-0880 | |
| Not Available |
| Full Name | Joy J Kain |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 865 Westfield Rd Ste B, Noblesville, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477530558 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 01042678 (Indiana) | Primary |
| Entity Name | St Vincent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
iCo Therapeutics Inc. today announced that the company has entered into a research collaboration agreement with JDRF, the worldwide leader for research to cure, treat, and prevent type 1 diabetes (T1D), to support the previously announced Phase 2 investigator sponsored clinical trial investigating iCo-007 in Diabetic Macular Edema.
California cut program budgets aimed at providing care for the poor while in Wyoming, the programs themselves are forced to close their doors because of a funding shortfall. In Kansas, lawmakers are examining — ahead of final consideration of health care reform in Congress — how they can shield themselves from health care mandates to carry insurance.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has applied to the U.S. Food and Drug Administration for orphan drug designation for ALS-886, a novel therapy to reduce and prevent tissue damage, for the treatment of Acute Respiratory Distress Syndrome (ARDS).
Cardioxyl Pharmaceuticals, Inc. announced today the positive results of a clinical trial demonstrating that CXL-1427, a novel potential treatment for acute decompensated heart failure (ADHF), was well tolerated in healthy volunteers.
A widely heralded Johns Hopkins safety initiative to reduce bloodstream infections in intensive care units (ICUs) was implemented in 30 states starting Feb. 1 and could save an estimated $3 billion dollars and 30,000 lives annually.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joy J Kain, MD 865 Westfield Rd Ste B, Noblesville, IN 46062-8938 Ph: () - | Joy J Kain, MD 865 Westfield Rd Ste B, Noblesville, IN 46062-8901 Ph: (317) 776-0880 |
News Archive
iCo Therapeutics Inc. today announced that the company has entered into a research collaboration agreement with JDRF, the worldwide leader for research to cure, treat, and prevent type 1 diabetes (T1D), to support the previously announced Phase 2 investigator sponsored clinical trial investigating iCo-007 in Diabetic Macular Edema.
California cut program budgets aimed at providing care for the poor while in Wyoming, the programs themselves are forced to close their doors because of a funding shortfall. In Kansas, lawmakers are examining — ahead of final consideration of health care reform in Congress — how they can shield themselves from health care mandates to carry insurance.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has applied to the U.S. Food and Drug Administration for orphan drug designation for ALS-886, a novel therapy to reduce and prevent tissue damage, for the treatment of Acute Respiratory Distress Syndrome (ARDS).
Cardioxyl Pharmaceuticals, Inc. announced today the positive results of a clinical trial demonstrating that CXL-1427, a novel potential treatment for acute decompensated heart failure (ADHF), was well tolerated in healthy volunteers.
A widely heralded Johns Hopkins safety initiative to reduce bloodstream infections in intensive care units (ICUs) was implemented in 30 states starting Feb. 1 and could save an estimated $3 billion dollars and 30,000 lives annually.
› Verified 3 days ago
Elizabeth Rourke, Pediatrics Medicare: Medicare Enrolled Practice Location: 9669 E 146th St Ste 250, Noblesville, IN 46060 Phone: 317-621-9926 Fax: 317-621-9676 | |
Dr. Meredith L Taylor, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 14540 Prairie Lakes Blvd N, Suite 102, Noblesville, IN 46060 Phone: 317-770-9353 Fax: 317-770-9358 | |
Dr. Noah Scott Kersey, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 9669 E 146th St Ste 250, Noblesville, IN 46060 Phone: 317-621-6333 | |
Marjorie Burke, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9669 E 146th St Ste 100, Noblesville, IN 46060 Phone: 317-621-3434 | |
Dr. Kara Lynn Gurchiek, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9669 E 146th St Ste 300, Noblesville, IN 46060 Phone: 317-621-9000 | |
Kathleen A Miller, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 14540 Prairie Lakes Blvd N Ste 200, Noblesville, IN 46060 Phone: 317-578-4193 | |
Theresa M P Mason, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 865 Westfield Rd Ste B, Noblesville, IN 46062 Phone: 317-776-0880 |